Hong Kong’s benchmark Hang Seng Index was up 1.2%, led by insurance stocks. Markets were likely digesting new measures announced by the China Securities Regulatory Commission to boost investments in the A-share market.
Asian stocks gained as President Donald Trump’s push to boost investment in artificial intelligence improved the outlook for the region’s tech firms.
The firm said only $5.6 million was spent developing the model. The programme's arrival has sparked competition fears, as tech titans -- including Nvidia, Meta and Alphabet -- have made huge investments worth hundreds of billions of dollars into AI products and sent their valuations soaring.
HONG KONG, Jan 28, 2025 (BSS/AFP) - Japanese tech firms sank Tuesday after a sell-off in US titans following news of China's DeepSeek chatbot, while the dollar rallied on a report saying Washington was considering universal tariffs on a range of goods.
Asian stocks were mixed on Wednesday after U.S. President Donald Trump's latest comments on tariffs raised uncertainty in Chinese markets. U.S. futures edged higher and oil
SoftBank Group’s shares rose more than 9% after Trump named the company as a participant in the ‘Stargate’ AI joint venture.
Global stocks are mixed as Trump's tariff comments stir uncertainty, impacting Asian markets. European stocks edge higher, buoyed by AI investment news, while U.S. markets show cautious optimism.
Global shares are trading mixed after Wall Street’s tech superstars tumbled as a competitor from China raised doubts over the recent artificial-intelligence market frenzy. Shares rose in early Tuesday trading in Germany and Britain while falling in France.
Day two of Donald Trump's second presidency culminated in an announcement that OpenAI, SoftBank Group and Oracle will ... under performers were China and Hong Kong, with the former's blue-chip ...
Concerns over the emergence of a low-cost Chinese generative AI model DeepSeek fuelled selling in tech stocks globally.
Trump targets BRICS over de-dollarization, warns of 100% tariffs. Markets brace for trade risks as US-China tensions threaten sentiment.
Wen Shuhao helped speed up the development of Pfizer’s Covid oral drug, Paxlovid. Now the chairman of Xtalpi wants to help make better solar panels and EV batteries.